Zegerid acid reflux drug yields positive clinical results

01/7/2008 | Boston Globe (tiered subscription model), The

A study on the effect of morning dosing on 24-hour gastric-acid control in patients with symptoms of gastroesophageal reflux disease showed that Zegerid helped patients maintain a gastric pH level of more than 4. The test subjects were able to sustain that level about 43% longer than patients taking Protonix, and 22% longer than those taking Prevacid, the report said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC